Literature DB >> 7549171

Subarachnoid neurolytic block under general anesthesia in a 3-year-old with neuroblastoma.

R B Patt1, R Payne, G A Farhat, S K Reddy.   

Abstract

CASE REPORT: A 3-year-old boy with neuroblastoma complained of severe pain in the left lower extremity. Pharmacologic management had previously been attempted, but severe pain continued, and further upward titration was complicated by sedative effects. METHODS AND
RESULTS: Because the focus of treatment had become the controlling of pain, a lumbosacral subarachnoid neurolytic block was performed under general anesthesia. One-time neurolysis was more acceptable to the family than a procedure like epidural analgesia, that requires greater management. Contrast medium was used to monitor the spread of the neurolytic. An epidural catheter was inserted during the neurolytic block procedure for possible future use. The short-term results were good--pain reports and opioid doses decreased greatly, although with increased incontinence. The boy had new abdominal distention and pain 5 days after neurolysis. Opioid doses and sedatives were increased. He died 3 days later.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549171     DOI: 10.1097/00002508-199506000-00010

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  3 in total

Review 1.  Breakthrough pain in cancer patients: new therapeutic approaches to an old challenge.

Authors:  S K Reddy; P Nguyen
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Pediatric Oncology: Managing Pain at the End of Life.

Authors:  Jennifer M Snaman; Justin N Baker; Jennifer H Ehrentraut; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

3.  Successful intrathecal neurolytic block for the management of cancer pain in a 10-year-old child: a case report.

Authors:  Shogo Tashiro; Kohei Godai; Yukihisa Daitoku; Tomoyo Sato; Kei Enohata; Natsue Kiyonaga; Kenichi Maekawa; Yuichi Kanmura
Journal:  JA Clin Rep       Date:  2021-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.